Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Xeris Biopharma Holdings, Inc.

NASDAQ: XERS · Life Sciences · 12 alerts · CIK 1867096

Share price
$16.70Close, Nov 16
Market cap
$3.05B
Shares outstanding
182.7MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Xeris Biopharma Holdings, Inc. filings on SEC EDGAR ↗

7:08 AM ET 8-K
Court & Legal Update

Xeris Biopharma Holdings Court & Legal Update

Xeris Biopharma Holdings filed patent infringement lawsuits in the U.S. District Court for the District of New Jersey against several pharmaceutical companies regarding its KEVEYIS® (dichlorphenamide) product. The lawsuits allege infringement of U.S. Patent No. 12,758,502 and seek injunctive relief and monetary damages to prevent the defendants from marketing generic versions of the drug.

Counterparty
Torrent Pharma Inc., Torrent Pharmaceuticals Limited, Cycle Pharmaceuticals Limited, Lemed Pharmacy III, LLC, Lemed Specialty Pharmacy Arizona, LLC, Rising Pharma Holdings, Inc., and Rising Pharma Specialties Pvt. Ltd.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.